Author

Yujie Liu

Icahn School of Medicine at Mount SinaiORCID 0009-0003-6138-858XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yujie Liu3 papers · Fudan University

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:bacteria (other)· 1 Research Focus:clustering· 1 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metagenomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Adam KawałekiD· 1 shared Alan TourancheauiD· 1 shared Anmin Ren· 1 shared Edward A. MeadiD· 1 shared Gang FangiD· 1 shared Jan‐Willem VeeningiD· 1 shared Jinzhao OuiD· 1 shared Katerina Junker· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Adam KawałekORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyCell Host & MicrobePeer-reviewedMay 19, 2026

Epigenetic phase variation in the gut microbiome enhances bacterial adaptation

Mi Ni, Katerina Junker, Yujie Liu…·Gang Fang

This study identifies epigenetic phase variation in the gut microbiome, showing it enhances bacterial adaptation through gene regulation and bet-hedging strategies.

13 citationstop 1%

humanmetagenomics

𝕏 PostBluesky

MicrobiologyNature CommunicationsPeer-reviewedJul 1, 2025

Genome-wide CRISPRi-seq identified ferredoxin-NADP reductase FprB as a synergistic target for gallium therapy in Pseudomonas aeruginosa

Yu Zhang, Tingting Zhang, Xue Xiao…·Xue Liu

The paper uses CRISPRi-seq to identify FprB as a synergistic target for gallium therapy in Pseudomonas aeruginosa, enhancing gallium's efficacy against infections.

17 citationstop 4%

bacteria (other)CRISPR screen

𝕏 PostBluesky